Amplifon S.p.A EBITDA Margin 2019-2025 | AMFPF
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Amplifon S.p.A (AMFPF) over the last 10 years. The current EBITDA margin for Amplifon S.p.A as of March 31, 2025 is .
| Amplifon S.p.A EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $2.38B | $0.54B | 22.80% |
| 2024-03-31 | $2.29B | $0.51B | 22.18% |
| 2023-03-31 | $2.07B | $0.43B | 20.93% |
| 2022-03-31 | $1.93B | $0.40B | 20.53% |
| 2021-03-31 | $1.83B | $0.73B | 39.80% |
| 2020-03-31 | $1.66B | $0.97B | 58.55% |
| 2019-03-31 | $1.68B | $1.33B | 78.80% |
| 2018-12-31 | $1.62B | $1.62B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $3.937B | $2.607B |
| Amplifon SpA provides hearing solutions and services. It operates principally in Italy, France, Spain, Portugal, Switzerland, Austria, Holland, the United States, Hungary and Egypt. Amplifon SpA is based in Milan, Italy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.038B | 26.53 |
| CVS Health (CVS) | United States | $82.289B | 10.23 |
| Elevance Health (ELV) | United States | $65.480B | 8.81 |
| Cencora (COR) | United States | $56.344B | 18.77 |
| DiDi Global (DIDIY) | China | $25.603B | 27.20 |
| Labcorp Holdings (LH) | United States | $22.243B | 17.68 |
| Natera (NTRA) | United States | $21.553B | 0.00 |
| BioMerieux (BMXMF) | France | $17.652B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.635B | 0.00 |
| CochLear (CHEOY) | Australia | $13.465B | 0.00 |
| ICON (ICLR) | Ireland | $12.898B | 12.41 |
| Medpace Holdings (MEDP) | United States | $12.635B | 33.44 |
| Solventum (SOLV) | United States | $12.460B | 12.85 |
| Viatris (VTRS) | United States | $11.496B | 4.09 |
| Revvity (RVTY) | United States | $9.959B | 17.55 |
| Sonic Healthcare (SKHHY) | Australia | $8.980B | 0.00 |
| Avantor (AVTR) | United States | $8.249B | 12.10 |
| HealthEquity (HQY) | United States | $7.996B | 35.02 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.686B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.329B | 13.91 |
| Bausch + Lomb (BLCO) | Canada | $4.825B | 32.45 |
| Sotera Health (SHC) | United States | $3.994B | 22.32 |
| BrightSpring Health Services (BTSG) | United States | $3.660B | 27.92 |
| GeneDx Holdings (WGS) | United States | $3.175B | 72.72 |
| Surgery Partners (SGRY) | United States | $2.915B | 36.68 |
| Alignment Healthcare (ALHC) | United States | $2.893B | 0.00 |
| Concentras Parent (CON) | United States | $2.753B | 17.46 |
| Organon (OGN) | United States | $2.342B | 2.55 |
| Premier (PINC) | United States | $1.922B | 14.59 |
| Progyny (PGNY) | United States | $1.870B | 39.54 |
| PACS (PACS) | United States | $1.731B | 0.00 |
| Ardent Health (ARDT) | United States | $1.723B | 6.65 |
| GoodRx Holdings (GDRX) | United States | $1.243B | 20.47 |
| Pediatrix Medical (MD) | United States | $1.230B | 8.21 |
| Teladoc Health (TDOC) | United States | $1.198B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.974B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Embecta (EMBC) | United States | $0.745B | 4.36 |
| AMN Healthcare Services Inc (AMN) | United States | $0.632B | 7.82 |
| CareDx (CDNA) | United States | $0.626B | 11.54 |
| Performant Healthcare (PHLT) | United States | $0.603B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.586B | 201.00 |
| Nutex Health (NUTX) | United States | $0.498B | 7.54 |
| Omada Health (OMDA) | $0.491B | 0.00 | |
| So-Young (SY) | China | $0.467B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.465B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.463B | 10.42 |
| SBC Medicals (SBC) | United States | $0.460B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.436B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.416B | 0.00 |
| Oncology Institute (TOI) | United States | $0.378B | 0.00 |
| Enhabit (EHAB) | United States | $0.369B | 24.27 |
| Agilon Health (AGL) | United States | $0.358B | 0.00 |
| LifeMD (LFMD) | United States | $0.319B | 0.00 |
| Beauty Health (SKIN) | United States | $0.278B | 0.00 |
| Shoulder Innovations (SI) | $0.185B | 0.00 | |
| DocGo (DCGO) | United States | $0.156B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.141B | 0.00 |
| KindlyMD (NAKA) | United States | $0.109B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.088B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.057B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| ModivCare (MODV) | United States | $0.033B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |